MedPath

ORENCIA

ORENCIA

Discontinued
DIN Number

02461919

Drug Class

Human

Market Date

N/A

Company
HC

bristol-myers squibb canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02461919
AIG Number0151647002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L04AA24 ABATACEPT
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

ABATACEPTActive
Strength: 125 MG / ML
Monograph: ABATACEPT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.